Friday, May 24, 2013   

Insurance regulator digs into Ping An deal
(01-10 18:08)

China's insurance regulator said it had asked insurer Ping An for more information about its proposed sale of a stake to a Thai tycoon, after media reports said the deal may collapse.
British bank HSBC said last month it would sell its stake in Ping An, China's second largest life insurer, to Dhanin Chearavanont's conglomerate the Charoen Pokphand Group for US$9.4 billion, AFP reports.
The China Insurance Regulatory Commission, which must approve the deal, said it had asked for more information but gave no details.
"The CIRC has already received the Ping An Group application for the equity transfer, and in accordance with rules carried out a preliminary examination and notified the company to submit supplementary materials,'' it said in a statement to AFP.
Ping An Insurance closed down 0.18 percent at 44.99 yuan in Shanghai trading on Thursday. It fell 1.38 percent to HK$67.80 in Hong Kong, where it is also listed.
   
Other Business breaking news:
Mando China puts listing plan on hold (2 hrs 42 mins ago)
Hang Seng ends lower (05-24 16:26)
German business confidence improves in May: survey (05-24 16:17)
European markets recover at open (05-24 16:14)
Another Indian drug supplier suffers from US ban (05-24 14:42)
Nikkei ends rollercoaster session in positive territory (05-24 14:36)
Nikkei dives 3pc (05-24 12:56)
Nikkei advances 2pc by break (05-24 10:56)
Argentina lawsuit imperils sovereign debt restructuring (05-24 09:57)
Hang Seng opens slightly higher (05-24 09:50)

More breaking news >>

© 2013 The Standard, The Standard Newspapers Publishing Ltd.
Contact Us | About Us | Newsfeeds | Subscriptions | Print Ad. | Online Ad. | Street Pts

 


Home | Top News | Local | Business | China | ViewPoint | CityTalk | World | Sports | People | Central Station | Spree | Features

The Standard

Trademark and Copyright Notice: Copyright 2013, The Standard Newspaper Publishing Ltd., and its related entities. All rights reserved.  Use in whole or part of this site's content is prohibited.   Use of this Web site assumes acceptance of the
Terms of Use, Privacy Statement and Copyright Policy.  Please also read our Ethics Statement.